These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 18166199)
1. The effect of hydroxyurea in spinal muscular atrophy cells and patients. Liang WC; Yuo CY; Chang JG; Chen YC; Chang YF; Wang HY; Ju YH; Chiou SS; Jong YJ J Neurol Sci; 2008 May; 268(1-2):87-94. PubMed ID: 18166199 [TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293 [TBL] [Abstract][Full Text] [Related]
4. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121 [TBL] [Abstract][Full Text] [Related]
5. Stat5 constitutive activation rescues defects in spinal muscular atrophy. Ting CH; Lin CW; Wen SL; Hsieh-Li HM; Li H Hum Mol Genet; 2007 Mar; 16(5):499-514. PubMed ID: 17220171 [TBL] [Abstract][Full Text] [Related]
6. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598 [TBL] [Abstract][Full Text] [Related]
7. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy. Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673 [TBL] [Abstract][Full Text] [Related]
8. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Jarecki J; Chen X; Bernardino A; Coovert DD; Whitney M; Burghes A; Stack J; Pollok BA Hum Mol Genet; 2005 Jul; 14(14):2003-18. PubMed ID: 15944201 [TBL] [Abstract][Full Text] [Related]
9. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy. Zapletalová E; Hedvicáková P; Kozák L; Vondrácek P; Gaillyová R; Maríková T; Kalina Z; Jüttnerová V; Fajkus J; Fajkusová L Neuromuscul Disord; 2007 Jun; 17(6):476-81. PubMed ID: 17475491 [TBL] [Abstract][Full Text] [Related]
10. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells. Boda B; Mas C; Giudicelli C; Nepote V; Guimiot F; Levacher B; Zvara A; Santha M; LeGall I; Simonneau M Eur J Hum Genet; 2004 Sep; 12(9):729-37. PubMed ID: 15162126 [TBL] [Abstract][Full Text] [Related]
11. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882 [TBL] [Abstract][Full Text] [Related]
13. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy. DiMatteo D; Callahan S; Kmiec EB Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930 [TBL] [Abstract][Full Text] [Related]
14. Spinal muscular atrophy: from gene to therapy. Wirth B; Brichta L; Hahnen E Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862 [TBL] [Abstract][Full Text] [Related]
15. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455 [TBL] [Abstract][Full Text] [Related]
16. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene. Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254 [TBL] [Abstract][Full Text] [Related]